Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified vaccinia virus ankara for the vaccination of neonates

Modified vaccinia virus ankara for the vaccination of neonates

US Patent 8372622 · Granted Feb 12, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RS2021
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RS2020
Recombinant modified vaccinia virus Ankara (MVA) Respiratory Syncytial Virus (RS2018
Poxviral vectors for low antibody response after a first priming immunization2018
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RS2017
Single high dose of MVA induces a protective immune response in neonates and inf2017
Single high dose of MVA induces a protective immune response in neonates and inf2017
Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RS2016
Recombinant poxvirus vector comprising tetanus toxin fragment C2016
Use of a modified poxvirus for the rapid induction of immunity against a poxviru2016
Vaccinia virus mutants containing the major genomic deletions of MVA2014
Use of a modified poxvirus for the rapid induction of immunity against a poxviru2014